Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2001-04-01 (25 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: THONON-LES-BAINS (74200), Haute-Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DELECLUSE : revenue, balance sheet and financial ratios
PHARMACIE DELECLUSE is a French company
founded 25 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in THONON-LES-BAINS (74200),
this company of category PME
shows in 2025 a net income positive of 48 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DELECLUSE (SIREN 438556896)
Indicator
2025
2024
2023
2022
2021
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
47 701 €
-43 317 €
17 069 €
33 396 €
38 279 €
52 105 €
67 793 €
51 663 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DELECLUSE generates positive net income of 48 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 52 k€ -> 48 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
47 701 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 21%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
20.676%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
71.981%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
2025
Debt ratio
97.941
81.076
65.023
44.833
37.296
33.344
30.991
20.676
Financial autonomy
42.875
45.76
50.554
59.504
63.985
65.504
63.653
71.981
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
20.682025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good
In 2025, the debt ratio of PHARMACIE DELECLUSE (20.68) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
71.98%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good
In 2025, the financial autonomy of PHARMACIE DELECLUSE (72.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 119.64. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2021
2022
2023
2024
2025
Liquidity ratio
132.592
105.742
98.375
100.122
94.987
93.077
114.823
119.645
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
119.642025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch+5 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DELECLUSE (119.64) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE DELECLUSE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DELECLUSE is estimated at
757 736 €
(range 514 203€ - 1 188 992€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
514k€757k€1188k€
757 736 €Range: 514 203€ - 1 188 992€
NAF 5 année 2025
Valuation method used
Net Income Multiple
47 701 €
×
15.9x
=757 736 €
Range: 514 203€ - 1 188 992€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DELECLUSE with other companies in the same sector:
Frequently asked questions about PHARMACIE DELECLUSE
What is the revenue of PHARMACIE DELECLUSE ?
The revenue of PHARMACIE DELECLUSE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DELECLUSE profitable?
Yes, PHARMACIE DELECLUSE generated a net profit of 48 k€ in 2025.
Where is the headquarters of PHARMACIE DELECLUSE ?
The headquarters of PHARMACIE DELECLUSE is located in THONON-LES-BAINS (74200), in the department Haute-Savoie.
Where to find the tax return of PHARMACIE DELECLUSE ?
The tax return of PHARMACIE DELECLUSE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DELECLUSE operate?
PHARMACIE DELECLUSE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart